Full OET Reading Test ABC-1
Full OET Reading Test ABC-1
Full OET Reading Test ABC-1
In the last few years, the concept of aspirin resistance has been
largely emphasised in the medical literature, although its definition,
mechanism, and specific guidelines for its management remain
unclear. Aspirin displays good antithrombotic activity. Various
laboratory parameters assessing the efficacy of aspirin like
bleeding time, platelet reactivity, thromboxane-A2 (TX-A2)
production, and measurement of platelet aggregation, have
confirmed the lack of its uniform effect on the platelets. Few
studies have reported aspirin resistance to the tune of 5 - 45%.
Various extrinsic and intrinsic factors influence the resistance.
Numerous studies reveal that aspirin resistance can be overcome by
combining it with another antithrombotic agent, i.e., clopidogrel.
Further, clopidogrel resistance has also been reported. So, much is
expected in the field of diagnostic tests in order to know the true
picture of aspirin resistance.
Go to “1” “2” “3” “4” “5” “6” “7” “8” “9” “10”
Questions“11”“12”“13”“14”“15”“16”“17”“18”“19”“20”
Text B
Mechanisms of aspirin resistance
The exact mechanisms are not clear:
True aspirin resistance:
The proposed factors for this type of resistance include:
i. Decreased bioavailability of aspirin.
ii. Accelerated platelet turnover introducing newly formed, non-
aspirinated platelets into the blood stream.
iii. Competition of aspirin with other NSAIDs (like ibuprofen)
preventing aspirin access at Serine 530 of Cox-I.
iv. Transcellular formation of TxA2 by aspirinated platelets from
PGH2 released by other blood cells or vascular cells.
v. TxA2 production by aspirin insensitive Cox-2 in newly formed
platelets or other cells.
vi. (Theoretical) presence of variant Cox-I which is less sensitive to
aspirin inhibition.
vii. Poor compliance by the patient.
Go to “1” “2” “3” “4” “5” “6” “7” “8” “9” “10”
Questions“11”“12”“13”“14”“15”“16”“17”“18”“19”“20”
Text C
Aspirin dosage
According to the Antithrombotic Trialists’ Collaboration, daily
doses of aspirin (75 - 150 mg) are as effective as higher doses for
prevention of thrombotic events and are associated with low risk of
bleeding. Bornstein et al in their study have shown that even 100
mg of aspirin completely inhibits Cox-1 enzyme, thus further
substantiating the fact that patients with resistance established
during low dose aspirin therapy may respond to higher doses. The
results of this study showed that aspirin in doses of 500 mg/day
significantly prolonged the time between first and second stroke (p
= 0.002) compared with lower doses. Helgason et al revealed that
an increase in the dose of aspirin to 625 that suboptimal reduction
of urinary 11-dehydro TxB2 level during aspirin treatment is
associated with increased risk for future MI and cardiovascular
death, thereby suggesting that “true aspirin resistance” may be a
clinically relevant phenomenon. Inadequate inhibition of TxA2
biosynthesis by aspirin can be seen in patients on ibuprofen
therapy, because of competition of these 14 mg/day in five patients
who were aspirin resistant with 325 mg/day showed aspirin
sensitivity. Another study has revealed that these patients remained
resistant with aspirin 1,300 mg. This shows that inadequate dose
cannot explain aspirin resistance in all subjects.
Go to “1” “2” “3” “4” “5” “6” “7” “8” “9” “10”
Questions“11”“12”“13”“14”“15”“16”“17”“18”“19”“20”
Text D
Management of aspirin resistance
Currently there are no specific guidelines for the management of
aspirin resistance. The first step is to enquire about the patient’s
compliance. Regarding optimal aspirin dosing, it is controversial.
No convincing data are available showing that the antithrombotic
effect of aspirin is dose related. The meta-analysis by Anti-
Thrombotic Trialist’s Collaboration refuted the claim that high
doses of aspirin (500 - 1,500 mg/day) were effective than low
doses (75 - 150 mg/day). Other method to manage aspirin
resistance is by addition of another antiplatelet agent – clopidogrel,
because CAPRIE trial has shown greater benefit of combination of
aspirin and clopidogrel compared with aspirin alone. The
combination of aspirin with clopidogrel is an ideal one since
clopidogrel inhibits another pathway of platelet activation.
However, till date, it is not clear whether the superiority of a
combination of clopidogrel and aspirin over aspirin is due to
clopidogrel compensation for aspirin non-responders. Resistance to
even clopidogrel has been reported, which is associated with an
increased risk of recurrent thrombotic events in patients with acute
MI.
.
Go to “1” “2” “3” “4” “5” “6” “7” “8” “9” “10”
Questions“11”“12”“13”“14”“15”“16”“17”“18”“19”“20”
Part A
TIME: 15 minutes
• Look at the four texts, A-D, in the separate Text Booklet.
• For each question, 1-20, look through the texts, A-D, to find the
relevant information.
• Write your answers on the spaces provided in this Question
Paper.
• Answer all the questions within the 15-minute time limit.
• Your answers should be correctly spelt.
QUESTIONS
Questions 1-7
For each question, 1-7, decide which text (A, B, C or D) the information
comes from. You may use any letter more than once.
In which text can you find information about
1. what are the factors of true aspirin resistance? _____
Go “Text “Text “Text “Text
to A” B” C” D”
2. how much of aspirin completely inhibits Cox-1 enzyme? _____
Go “Text “Text “Text “Text
to A” B” C” D”
3. what will happen if aspirin compete with other NSAIDs? _____
Go “Text “Text “Text “Text
to A” B” C” D”
4. how the the true picture of aspirin resistance is revealed? _____
Go “Text “Text “Text “Text
to A” B” C” D”
5. what are the parameters for assessing the efficacy of aspirin?
_____
Go “Text “Text “Text “Text
to A” B” C” D”
6. list the methods to manage aspirin resistance? _____
Go “Text “Text “Text “Text
to A” B” C” D”
7. whether true aspirin resistance is a clinically relevant
phenomenon? _____
Go “Text “Text “Text “Text
to A” B” C” D”
Questions 8-13
Answer each of the questions, 8-13, with a word or short phrase from one of
the texts. Each answer may include words, numbers or both.
Answer Key
“Practice Test 1”
Practice Test 2
READING SUB-TEST – QUESTION PAPER: PART B & C
TIME: 45 MINUTES
INSTRUCTIONS TO CANDIDATES:
DO NOT open this Question Paper or the Text Booklet until
you are told to do so.
Write your answers on the spaces provided on this Question
Paper.
You must answer Part B & C within the 45-minute time limit.
One mark will be granted for each correct answer.
Answer ALL questions.
Marks are NOT deducted for incorrect answers.
At the end of the 45 minutes, hand in this Question Paper and
the Text Booklet.
DO NOT remove OET material from the test room.
Part B
In this part of the test, there are six short extracts relating to the
work of health professionals. For questions 1-6, choose the answer
(A, B or C) which you think fits best according to the text.
Anaesthetic Machines
The anaesthetic machine (or anaesthesia machine in America) is used by
anaesthesiologists and nurse anaesthetists to support the administration of
anaesthesia. The most common type of anaesthetic machine is the
continuous-flow anaesthetic machine, which is designed to provide an
accurate and continuous supply of medical gases (such as oxygen and nitrous
oxide), mixed with an accurate concentration of anaesthetic vapour (such as
halothane or isoflurane), and deliver this to the patient at a safe pressure and
flow. Modern machines incorporate a ventilator, suction unit, and patient
monitoring devices.
1. The manual is giving information about
A. how to use anaesthetic machines
B. types of anaesthetic machines
C. an overview of anaesthetic machines
mHealth
The use of mobile technologies for data collection about individuals and
interactive information services are a part of a growing area of eHealth called
mHealth. The GOe published a volume on this subject in 2011 which
documents the uptake of mHealth worldwide by types of initiatives and main
barriers to scale. Mobile technologies are emerging as a powerful tool for
health information transfer including making patient information portable.
Such technologies can be more fully utilized through electronic patient
information such as EMRs and EHRs. Electronic records will work best,
however, if there are standards in place for their use and interoperability.
5. The note tells us that the mHealth
A. is a published volume on the GOe
B. is a powerful tool for information transfer
C. makes patient information portable
Answer Key
“Practice Test 2”
Practice Test 3
READING SUB-TEST – QUESTION PAPER: PART B & C
TIME: 45 MINUTES
INSTRUCTIONS TO CANDIDATES:
DO NOT open this Question Paper or the Text Booklet until
you are told to do so.
Write your answers on the spaces provided on this Question
Paper.
You must answer Part B & C within the 45-minute time limit.
One mark will be granted for each correct answer.
Answer ALL questions.
Marks are NOT deducted for incorrect answers.
At the end of the 45 minutes, hand in this Question Paper and
the Text Booklet.
DO NOT remove OET material from the test room.
Part C
In this part of the test, there are two texts about different aspects of
healthcare. Choose the answer (A, B, C or D) which you think fits
best according to the text.
Answer Key
“Practice Test 4”